David Owens Nexalin Technology, Inc. (NXL) insider trading activity
David Owens is Chief Medical Officer of Nexalin Technology, Inc.. Currently has a direct ownership of 147,793 shares of NXL, which is worth approximately $97,543. The most recent transaction as insider was on Aug 13, 2024, when has been sold 1,000 shares (Common Stock) at a price of $0.95 per share, resulting in proceeds of $950. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
148K
0.68%
3M change
4.69%
12M change
Total Value Held
$97,543
David Owens Transaction History
DO
David Owens
Chief Medical Officer
Atlanta, GA